期刊文献+

影响上皮性卵巢癌复发患者预后相关临床病理因素分析 被引量:17

Analysis of Clinical and Pathological Prognostic Factors for Recurrent Epithelial Ovarian Cancer
在线阅读 下载PDF
导出
摘要 目的分析影响上皮性卵巢癌(epithelial ovarian cancer,EOC)复发患者预后的相关临床病理因素。方法采用Kaplan-meier生存率曲线,Log rank检验和Cox模型多因素回归分析法对92例临床病理及随访资料完整的复发癌患者进行影响其预后的相关因素分析。结果 (1)92例复发上皮性卵巢癌临床病例的总体中位生存时间是18月(95%CI:16.052~19.948);(2)Kaplan-Meier单因素分析提示,FIGO分期、复发距离末次化疗时间、复发部位、最大复发病灶、复发后伴有腹水、CA125升高、复发后二次肿瘤细胞减灭术、再次治疗化疗方案是影响复发EOC患者的重要预后因素(P<0.1)。而年龄、肿瘤细胞分级、初次治疗方案与预后无关(P>0.1);(3)Cox回归分析结果显独示,复发后再次治疗化疗方案、最大复发病灶大小、复发部位是影响患者预后的独立危险因素。结论多个临床病理因素影响复发上皮性卵巢癌预后,其中复发后再次治疗化疗方案、最大复发病灶大小、复发部位是影响患者预后的独立危险因素。 Objective To analyze the clinical and pathological prognostic factors of recurrent epithelial o- varian cancer. Methods Kaplan-meier survival curves, Log-rank test and Cox multivariate test regression were used to analyze clinical and pathological prognostic factors of relapse epithelial ovarian cancer in 92 cases with recurrent epithelial ovarian cancer which clinical pathology and follow-up data was completed. Results (1) Ninety two patients with recurrent epithelial ovarian carcinoma cases overall median survival time was 18 months (95%CI:16. 065-19. 948). (2) Kaplan-Meier univariate analysis showed that FIGO stage,recurrence time from the last chemotherapy, recurrence site, the largest recurrence lesion, relapse with ascites, CA125 increased, secondary cytoreductive surgery, chemotherapy program for recurrence was the impact of important prognostic factor for re-treatment patients with recurrent EOC (P〈0.1). But there was no relationship between age, grade of tumor cell, initial treatment plan and prognosis(P〉0.1 ). (3) The Gox regression analysis showed that re-treatment regimen after relapse, the maximum recurrence of tumor size, recurrence site was an independent prognostic risk factor. Conclusion There are multiple clinical and pathological factors for affeeting prognosis of recurrence epithelial ovarian cancer. Re-treatment regimen after relapsed, the maximum recurrence of tumor size, recurrence site are independent prognostic risk factors.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第10期1228-1232,共5页 Cancer Research on Prevention and Treatment
关键词 上皮性卵巢癌 肿瘤复发 预后 COX模型 Epithelial ovarian cancer Tumor recurrence Prognosis Cox model
作者简介 现工作单位:641000四川内江,内江市第二人民医院妇产科,作者简介:党彩玲(1975-),女,硕士,主要从事妇科肿瘤研究 通信作者:李力,Email:lili@gxmu.edu.cn.
  • 相关文献

参考文献12

  • 1Jemal A,Siegel R,Xu J, et al. Cancer statistics,2010[J]. CA Cancer J Clin,2010,60(5) :277-300.
  • 2Matulonis UA,Horowitz NS,Campos SM,et al. Phase II stud- y of carboplatin and pemetrexed for the treatment of platinum sensitive recurrent ovarian cancer [J]. J Clin Oncol, 2008, 26 (35):5761-6.
  • 3Sharma R,Graham J, Mitchell H, et al. Extended weekly dose- dense paclitaxel/ carboplatin is feasible and active in heavily pre treated platinum-resistant recurrent ovarian caneer[J]. B J Cancer, 2009,100 ( 5 ):707-12.
  • 4Hoekstra AV, Hurteau J A, Kirschner CV, et al. The combina- tion of monthly carboplatin and weekly paclitaxel is highly ac tive for the treatment of recurrent ovarian cancer[J]. Gynecol Oncol,2009,115(3) :377-81.
  • 5Onda T, Yoshikawa H, Yasugi T, et al. Secondary cytoreduc tive surgery for recurrent epithelial ovarian carcinoma : proposal for patients selection[J]. Br J Cancer,2005,92(6) : 1026-32.
  • 6Park JY, Eom JM, Kim DY, et al. Secondary cytoreductive sur gery in the management of platinum-sensitive recurrent epithe- lial ovarian cancer[J]. J Surg Oncol,2010,101 (5):418-24.
  • 7Rema PN, Suchetha S, Mathew AP, et al. Secondary cytoreduc- tion in epithelial ovarian cancer recurrence:a perspective from a regional cancer center in India[J]. J Reprod Med,2009,54(8) : 506-10.
  • 8Schorge JO, Wingo SN, Bhore R, et al. Secondary cytoreductive surgery for recurrent platinum sensitive ovarian cancer[J]. Int J Gynaecol Obstet,2010,1118(2) : 123-7.
  • 9Tian WJ ,Jiang R, Cheng X, et al. Surgery in recurrent epitheli al ovarian cancer: benefits on Survival for patients with residual disease of 0.1-1 cm after secondary cytoreduction [J]. J Surg Oncol, 2010,101 (3) : 244-50.
  • 10Zang RY,Harter P,Chi DS,et al. Predictors of survival in pa tients with recurrent ovarian cancer undergoing secondarycy toreductive surgery based on the pooled analysis of an interna tional collaborative cohort [J]. Br J Cancer, 2011, 105 ( 7 ):890-6.

同被引文献128

引证文献17

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部